AEMD — Aethlon Medical Balance Sheet
0.000.00%
- $3.21m
- -$2.30m
Annual balance sheet for Aethlon Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 9.86 | 17.1 | 14.5 | 5.44 | 5.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.149 | 0.128 | 0 | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10.4 | 18.2 | 15.1 | 6.23 | 5.95 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.201 | 1.14 | 2.3 | 1.9 | 1.28 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 10.7 | 19.4 | 17.5 | 8.25 | 7.36 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.38 | 1.82 | 1.51 | 1.83 | 1.9 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.24 | 2.28 | 2.44 | 2.48 | 2.24 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 9.43 | 17.1 | 15.1 | 5.77 | 5.12 |
Total Liabilities & Shareholders' Equity | 10.7 | 19.4 | 17.5 | 8.25 | 7.36 |
Total Common Shares Outstanding |